glp 1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. “Use of GLP-1 RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 receptor agonist use for
Pay in 4 interest-free payments of $7.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
![glp 1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of GLP-1 RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 receptor agonist use for](https://www.healio.com/~/media/slack-news/endocrinology/infographics/et1122bezin_mm_graphic_01_web.jpg)
![glp 1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of GLP-1 RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 receptor agonist use for](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2025/08/15/16/24/glp-1ra-767x535.jpg)
![glp 1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of GLP-1 RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 receptor agonist use for](https://www.thyroid.org/wp-content/uploads/2019/05/thyroid-research.jpg)
![glp 1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of GLP-1 RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 receptor agonist use for](https://cdn.prod.website-files.com/62aec59ac7c1e4f6f1719e4a/69130fb9ffc1b2514da57196_sZaQ-DpP9eOL5tchseCyX4AbJequVWVFMa5MNuraAS4.png)

















